The Role of Image Surveillance in Patients with Diffuse Large B-Cell Lymphoma: A Single-Center Validation Study

Conclusion:These results indicate that routine image surveillance in DLBCL patients during their first CR does not improve OS and EFS. However, B symptoms at first diagnosis was a significant factor for OS in both the symptom and imaging group, Patients with B symptoms at diagnosis might receive a benefit of image surveillance.DisclosuresNishimura: Chugai pharmaceutical inc, Roche: Other: commissioned work. Mishima: Chugai pharmaceutical inc, Roche: Other: commissioned work. Yokoyama: Chugai pharmaceutical inc, Roche: Other: commissioned work. Terui: Celgene: Honoraria; Bristol myers Squib: Honoraria; Janssen Pharmaceutical KK: Honoraria; Takeda pharmaceutical: Honoraria; Novartis pharma: Honoraria.

Source: Blood - November 21, 2018 Category: Hematology Authors: Fukuta, T., Nishimura, N., Shirouchi, Y., Nishihara, A., Inoue, N., Uryu, H., Kusano, Y., Mishima, Y., Tsuyama, N., Takeuchi, K., Yokoyama, M., Terui, Y. Tags: 627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)-Results from Retrospective/Observational Studies: Poster II Source Type: research